Covered recipient · General Payments record
STEPHANIE R BEY
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$756.84
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $344.72 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $156.78 | 8 |
| Celgene Corporation | $61.28 | 4 |
| Madrigal Pharmaceuticals | $58.21 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.71 | 1 |
| Gilead Sciences, Inc. | $15.76 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.67 | 1 |
| PFIZER INC. | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.15 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106523116 | CMS |
| ABBVIE INC. | $16.55 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106523118 | CMS |
| ABBVIE INC. | $22.56 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106523120 | CMS |
| ABBVIE INC. | $19.50 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106523122 | CMS |
| ABBVIE INC. | $29.95 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106523124 | CMS |
| ABBVIE INC. | $16.36 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106523126 | CMS |
| ABBVIE INC. | $19.47 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106523128 | CMS |
| ABBVIE INC. | $17.24 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106523130 | CMS |
| Celgene Corporation | $15.16 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101091299 | CMS |
| Celgene Corporation | $15.44 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101091303 | CMS |
| Celgene Corporation | $15.34 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101091307 | CMS |
| Celgene Corporation | $15.34 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101091309 | CMS |
| Gilead Sciences, Inc. | $15.76 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133713627 | CMS |
| Madrigal Pharmaceuticals | $24.28 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144187654 | CMS |
| Madrigal Pharmaceuticals | $33.93 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144187656 | CMS |
| PFIZER INC. | $14.31 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130923051 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.67 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151148976 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.71 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137713963 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.